Lessons learned from hyponatremia associated with hyperthermic intraperitoneal chemoperfusion with oxaliplatin

Peritoneal Dialysis International

Volumn 28, Issue 1, 2008, Pages 32-34

  Nguyen, Minhtri K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; OXALIPLATIN; POTASSIUM; SODIUM; WATER; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

CARCINOMATOUS PERITONITIS; CYTOREDUCTIVE SURGERY; DIABETES MELLITUS; DIALYSATE; DIALYSIS MEMBRANE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; HYPERTHERMIC THERAPY; HYPONATREMIA; MEMBRANE TRANSPORT; NOTE; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SODIUM TRANSPORT; ULTRAFILTRATION; ELECTROLYTE BALANCE; INFUSION; METABOLISM; METHODOLOGY; PLASMA; REGIONAL PERFUSION;

ANTINEOPLASTIC AGENTS; BLOOD GLUCOSE; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; HYPERTHERMIA, INDUCED; HYPONATREMIA; INFUSIONS, PARENTERAL; ORGANOPLATINUM COMPOUNDS; PLASMA; SODIUM; WATER-ELECTROLYTE BALANCE;

EID: 42449145656     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080802800107     Document Type: Note

References (13)

1. Edelman IS, Leibman J, O'Meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolality and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 1958; 37:1236-56.
2. Nguyen MK, Kurtz I. A new formula for predicting alterations in the plasma sodium concentration in peritoneal. dialysis. Am J Physiol Renal Physiol 2005; 288: F1113-F1117.
3. Burkart JM, Nolph KD. Peritoneal dialysis. In: Brenner BM, ed.The Kidney. 5th ed. Philadelphia: W.B. Saunders; 1996: 2507-75.
4. Katz M. Hyperglycemia-induced hyponatremia. Calculation of expected sodium depression. N Engl J Med 1973; 289:843-4.
5. Mak RH. Impact of end-stage renal disease and dialysis on glycemic control. Semin Dial 2002; 13:4-8.
6. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999; 106:399-403.
7. De Somer F, Ceelen W, Delanghe J, De Smet D, Vanackere M, Pattyn P, et al. Severe hyponatremia, hyperglycemia, and hyperlactatemia are associated with intraoperative hyperthermic intraperitoneal chemoperfusion with oxaliplatin. Perit Dial Int 2008; 28:61-6.
8. Ceelen WP, Hesse U, De Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000; 87:1006-15.
9. Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex. Pharm Res 2004; 21:891-4.
10. Kurtz I, Nguyen MK. Evolving concepts in the quantitative analysis of the determinants of the plasma water sodium concentration and the pathophysiology and treatment of the dysnatremias. Kidney Int 2005; 68: 1982-93.
11. Nguyen MK, Ornekian V, Butch AW, Kurtz I. A new method for determining the plasma water content: application in pseudohyponatremia. Am J Physiol Renal Physiol 2007; 292:F1652-F1656.
12. Burnett RW, Covington AK, Fogh-Andersen N, Kulpmann WR, Lewenstam A, Maas AHJ, et al. Use of ion-selective electrodes for blood electrolyte analysis. Recommendations for nomenclature, definitions and conventions. Clin Chem Lab Med 2000; 38:363-70.
13. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989; 7(2-3): 95-108.